(Q83920042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Intensive glucose control and risk of cancer in patients with type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

John Chalmers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Marie Louise De Bruin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

9

D E Grobbee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

4

A P Kengne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

G Stefansdottir

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

M J Knol

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

H G M Leufkens

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A Patel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

M Woodward

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

21 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1608-1614

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21509444%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00125-011-2104-x

29 January 2020

exact match

0 references

cites work

Association of markers of insulin and glucose control with subsequent colorectal cancer risk

1 reference

12 December 2020

Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria.

1 reference

12 December 2020

The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas

1 reference

12 December 2020

Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials

1 reference

12 December 2020

Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation

1 reference

12 December 2020

Insulin glargine and cancer--an unsubstantiated allegation

1 reference

12 December 2020

Prospective study of hyperglycemia and cancer risk.

1 reference

12 December 2020

Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region

1 reference

12 December 2020

Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

1 reference

12 December 2020

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

12 December 2020

Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry

1 reference

12 December 2020

Effects of intensive glucose lowering in type 2 diabetes

1 reference

12 December 2020

The role of the IGF system in cancer growth and metastasis: overview and recent insights

1 reference

12 December 2020

Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression.

1 reference

12 December 2020

Does insulin therapy promote, reduce, or have a neutral effect on cancers?

1 reference

12 December 2020

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

12 December 2020

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

1 reference

12 December 2020

The role of insulin receptors and IGF-I receptors in cancer and other diseases

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

12 December 2020

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

1 reference

12 December 2020

Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure.

1 reference

12 December 2020

Diabetes and risk of incident cancer: a large population-based cohort study in Israel

1 reference

12 December 2020

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

1 reference

12 December 2020

1 reference

12 December 2020

Insulin glargine and malignancy: an unwarranted alarm

1 reference

12 December 2020

Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts

1 reference

12 December 2020

Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan

1 reference

12 December 2020

Does diabetes therapy influence the risk of cancer?

1 reference

12 December 2020

Serum insulin-like growth factor-I and breast cancer.

1 reference

12 December 2020